We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+1.01%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$147M
AUM Growth
-$48.9M
Cap. Flow
-$49.1M
Cap. Flow %
-33.49%
Top 10 Hldgs %
52.44%
Holding
166
New
58
Increased
10
Reduced
31
Closed
40

Top Buys

Rank Stock Value
1
BPL
Buckeye Partners, L.P.
BPL
+$2.98M
2
AGN
Allergan plc
AGN
+$2.9M
3
CY
Cypress Semiconductor
CY
+$2.89M
4
BKNG icon
Booking.com
BKNG
+$387K
5
ALV icon
Autoliv
ALV
+$278K

Top Sells

Rank Stock Value
1
DELL icon
Dell
DELL
+$42.4M
2
FNSR
Finisar Corp
FNSR
+$2.99M
3
RHT
Red Hat Inc
RHT
+$2.94M
4
APC
Anadarko Petroleum
APC
+$2.63M
5
UBS icon
UBS Group
UBS
+$1.58M

Sector Composition

Rank Sector Weight
1 Technology 35.88%
2 Healthcare 15.18%
3 Consumer Discretionary 11.65%
4 Communication Services 4.09%
5 Energy 3.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
STR
101
DELISTED
Sitio Royalties
STR
$67K 0.05%
+2,900
New +$80.7K
AFMD
102
DELISTED
Affimed
AFMD
$64K 0.04%
+2,170
New +$64.6K
EGY icon
103
Vaalco Energy
EGY
$608M
$63K 0.04%
+30,900
New +$54.5K
RIGL icon
104
Rigel Pharmaceuticals
RIGL
$765M
$63K 0.04%
+3,380
New +$69.8K
MNKD icon
105
MannKind Corp
MNKD
$1.29B
$61K 0.04%
+48,600
New +$56.6K
OSG
106
DELISTED
Overseas Shipholding Group Inc.
OSG
$61K 0.04%
+35,000
New +$62.7K
JNCE
107
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$61K 0.04%
+18,300
New +$73.3K
CRBP icon
108
Corbus Pharmaceuticals
CRBP
$179M
$59K 0.04%
+407
New +$70.9K
TCRT icon
109
Alaunos Therapeutics
TCRT
$4.86M
$59K 0.04%
+91
New +$72.2K
AKBA icon
110
Akebia Therapeutics
AKBA
$234M
$58K 0.04%
+14,800
New +$63.4K
LEE icon
111
Lee Enterprises
LEE
$183M
$58K 0.04%
+2,840
New +$57.9K
OPCH icon
112
Option Care Health
OPCH
$3.69B
$57K 0.04%
+4,450
New +$54.8K
MEET
113
DELISTED
The Meet Group, Inc. Common Stock
MEET
$57K 0.04%
+17,300
New +$60.1K
ASRT
114
DELISTED
Assertio
ASRT
$56K 0.04%
+723
New +$94.1K
MCHX icon
115
Marchex
MCHX
$77.5M
$56K 0.04%
+17,700
New +$68.2K
CDMO
116
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$55K 0.04%
+10,300
New +$63.9K
ATHX
117
DELISTED
Athersys, Inc. Common Stock
ATHX
$55K 0.04%
+1,640
New +$58.1K
AGEN
118
Agenus
AGEN
$282M
$54K 0.04%
+1,060
New +$56.7K
PTN
119
Palatin Technologies
PTN
$13.9M
$53K 0.04%
+47
New +$55.2K
CETV
120
DELISTED
Central European Media Enterprises Ltd
CETV
$53K 0.04%
+11,800
New +$53.3K
ACHN
121
DELISTED
Achillion Pharmaceuticals
ACHN
$53K 0.04%
+14,800
New +$57.1K
TLPH icon
122
Talphera
TLPH
$73.7M
$50K 0.03%
+1,135
New +$55.8K
SRGA
123
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
$49K 0.03%
+577
New +$61.6K
PDLI
124
DELISTED
PDL BioPharma, Inc.
PDLI
$49K 0.03%
+22,900
New +$61.2K
BDSI
125
DELISTED
BioDelivery Sciences International, Inc.
BDSI
$45K 0.03%
+10,800
New +$46.1K
3 4
5
6 7

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return

HighVista Strategies's Q3 2019 Portfolio in Review

As of Q3 2019, HighVista Strategies held 166 positions worth $147M, down 25% from $195M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

HighVista Strategies withdrew a net $49.1M in Q3 2019, closing 40 positions and reducing 31 holdings. Its most notable exit was Finisar Corp, an estimated $2.99M position sold in full.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 49% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, HighVista Strategies opened a new position in Buckeye Partners, L.P. worth $2.97M.

  • HighVista Strategies's largest Q3 2019 buy was Buckeye Partners, L.P.: 72,358 shares worth $2.97M.
  • HighVista Strategies added most to Allergan plc in Q3 2019, an estimated $2.9M increase.
  • HighVista Strategies's biggest Q3 2019 reduction was Dell, cutting an estimated $42.4M.
  • HighVista Strategies fully exited Finisar Corp in Q3 2019, selling an estimated $2.99M.
  • HighVista Strategies's ten largest holdings make up 52% of its $147M portfolio in Q3 2019.
  • HighVista Strategies opened 58 new positions and closed 40 in Q3 2019.
  • HighVista Strategies's portfolio value fell 25% quarter-over-quarter to $147M.

Based on HighVista Strategies's 13F filing for Q3 2019, filed 14 Nov 2019.